Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study

Molecular phenotypes of DCIS predict overall and invasive recurrence

(2015) K. E. Williams et al.   ANNALS OF ONCOLOGY

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ

(2015) G. Curigliano et al.   ANNALS OF ONCOLOGY

Early (

(2015) Tibor Tot   ANNALS OF SURGICAL ONCOLOGY

Translating the concept of intrinsic subtypes into an oncoplastic cohort of more than 1000 patients – predictors of recurrence and survival

(2015) M. Rezai et al.   BREAST

CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping

(2015) T. O. Nielsen et al.   CLINICAL CANCER RESEARCH

Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights

(2015) Charlotte K. Y. Ng et al.   JNCI-Journal of the National Cancer Institute

Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights

(2015) Charlotte K. Y. Ng et al.   JNCI-Journal of the National Cancer Institute

Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: American Society of Clinical Oncology Endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology Consensus Guideline

(2014) Thomas A. Buchholz et al.   JOURNAL OF CLINICAL ONCOLOGY

HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy

(2014) Haixia Jia et al.   World Journal of Surgical Oncology

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study

(2013) Wenjing Zhou et al.   BMC CANCER

Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands

(2013) L.N. van Steenbergen et al.   BREAST

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

(2013) M Lazzeroni et al.   BRITISH JOURNAL OF CANCER

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

(2013) Mila Donker et al.   JOURNAL OF CLINICAL ONCOLOGY

Ductal Carcinoma in Situ of the Breasts: Review of MR Imaging Features

(2013) Heather I. Greenwood et al.   RADIOGRAPHICS

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

(2012) E Rakovitch et al.   BRITISH JOURNAL OF CANCER

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

(2012) Aleix Prat et al.   JOURNAL OF CLINICAL ONCOLOGY

Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study

(2012) Cristiana Vidali et al.   Radiation Oncology

In search of triple-negative DCIS: tumor-type dependent model of breast cancer progression from DCIS to the invasive cancer

(2012) Sven Kurbel   TUMOR BIOLOGY

Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study

(2011) Yinghao Su et al.   BMC CANCER

Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence

(2011) K. Han et al.   CLINICAL ONCOLOGY

A refined molecular taxonomy of breast cancer

(2011) M Guedj et al.   ONCOGENE

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease

(2010) S E Clark et al.   BRITISH JOURNAL OF CANCER

Breast Cancer Subtypes and the Risk of Local and Regional Relapse

(2010) K. David Voduc et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiologic-Pathologic Correlation of Ductal Carcinoma in Situ

(2010) Takayuki Yamada et al.   RADIOGRAPHICS

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004

(2009) Carol A. Parise et al.   Breast Journal

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Screening caused rising incidence rates of ductal carcinoma in situ of the breast

(2008) L. N. van Steenbergen et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy

(2008) Paul L. Nguyen et al.   JOURNAL OF CLINICAL ONCOLOGY